- Capital Cube•2 months ago
Click here to see latest analysisAradigm Corp. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Aradigm Corp. – Alexza Pharmaceuticals, Inc., Windtree Therapeutics, Inc., MannKind Corporation, GlaxoSmithKline plc Sponsored ADR, Pfizer Inc., Johnson & Johnson, Innoviva, Inc., Insmed Incorporated and Gilead Sciences, Inc. (ALXA-US, […] (Read more...) The post Aradigm Corp. :ARDM-US: Earnings Analysis: Q1, 2016 By the Numbers appeared first on CapitalCube.
- Associated Press•2 months ago
The Hayward, California-based company said it had a loss of 55 cents per share. The specialty pharmaceutical company posted revenue of $6 million in the period. The company's shares closed at $4.61. A ...
|Ask||13.77 x 1600|
|52wk Range||2.60 - 7.90|
|Day's Range||4.71 - 4.71|
|Avg Vol (3m)||6,604|
As of 3:46 PM EDT. Market closed.